Illumina (ILMN) Debt to Equity Ratio
Current and historical debt to equity ratio values for Illumina (ILMN) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$35.894B||$2.752B|
|Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.|